Articles
Benign Prostatic Hyperplasia (BPH) Procedures and its Growth prospect in the Near Future
by Pramod Kumar Digital Marketing ProfessionalIncreasing life expectancy and fall in the birth rates are
the major reasons for rise in the aging population. The people in this category
require extensive care, since they are more prone to illness due to low
immunity levels and longer recovery time. Increase in the aging population in
the U.S., Germany, China and India in the next few years, is expected to create
high demand for BPH treatment devices, since the population aged 50 years and
above is more prone to BPH, and therefore tend to opt for various treatments
that involve the use of procedures such as TURP, prostate implants and laser
based treatments. Thus, growing aging population acts as a strong driver
supporting the increase in the number of BPH procedures performed.
As per the findings of the research, surgical procedure held
the largest share in the global BPH procedures,
primarily due to increasing prevalence of BPH disorders. The number of laser
based procedure is expected to register fastest growth during the forecast
period since these procedures are as effective as surgical procedures and
reduce the hospital stay time. Hospitals held the largest share of the number
of BPH procedures performed, based on the end user. Ambulatory surgical centers
are expected to witness the highest inflow of BPH patients for treatment during
the forecast period, due to development of technologically advanced BPH
procedures and rising prevalence of BPH disorders leading to the growth in the
number of patients treated in the ambulatory surgical centers.
Download Report Sample at: https://www.psmarketresearch.com/market-analysis/benign-prostatic-hyperplasia-procedures/report-sample
Geographically, Europe accounted for the largest number of
BPH procedures done in 2016. Growing ageing population, lower cost of BPH
treatment as compared to the U.S., high healthcare spending, and technological
advancements in the field of urological procedures technology are some of the factors
driving the growth of the BPH procedures in the Europe. France, Germany and the
U.K. are expected to be the most promising countries for the growth in number
of the BPH procedures. In June 2016, National Institute of Health and Care
Excellence (NICE) approved GreenLight XPS laser treatment for the treatment of
BPH. NICE added that the widespread adoption of the procedure could save the
National Health Services (NHS) an estimated $4.3 million (£3 million) a year.
Asia-Pacific is expected to witness the high number of BPH procedures performed
during the forecast period, owing to the rising prevalence of BPH disorders,
increasing disposable income, aging population, and growing efforts to increase
awareness about advanced BPH treatment procedures.
Some of the other key players operating in the global BPH
procedures include NxThera, Inc., Boston Scientific Corporation, Urologix,
LLC., Karl Storz GmbH & Co. KG, Lumenis Ltd., Olympus Corporation, Advin
Urology, Convergent Laser Technologies, Richard Wolf GmbH, Medtronic Plc.
Sponsor Ads
About Pramod Kumar 
Digital Marketing Professional
88 connections, 2 recommendations, 268 honor points.Joined APSense since, July 17th, 2017, From Ave, United States.
Created on Aug 8th 2019 02:33. Viewed 271 times.
